Valuation: OrthoPediatrics Corp.

Market Cap 655M 561M 525M 480M 905M 62.68B 915M 6.21B 2.41B 31.47B 2.46B 2.4B 104B P/E 2026 *
-20.5x
P/E 2027 * -30.8x
Enterprise Value 655M 561M 525M 480M 905M 62.68B 915M 6.21B 2.41B 31.47B 2.46B 2.4B 104B EV / Sales 2026 *
2.45x
EV / Sales 2027 * 2.19x
Free-Float
67.68%
Yield 2026 *
-
Yield 2027 * -
1 day-2.26%
1 week+1.50%
Current month+24.17%
1 month+32.86%
3 months+36.47%
6 months+55.91%
Current year+41.16%
1 week 25
Extreme 25
26.74
1 month 19.07
Extreme 19.07
26.74
Current year 14.42
Extreme 14.42
26.74
1 year 14.42
Extreme 14.42
26.74
3 years 14.42
Extreme 14.42
38.99
5 years 14.42
Extreme 14.42
73.91
10 years 14
Extreme 14.0001
73.91
Manager TitleAgeSince
Chief Executive Officer 47 02/06/2021
Director of Finance/CFO 58 31/01/2015
Chief Tech/Sci/R&D Officer - 31/12/2021
Director TitleAgeSince
Director/Board Member 47 02/11/2021
Chairman 75 02/06/2021
Director/Board Member 70 31/12/2010
Date Insider Type Main position Quantity % Market Cap.
29/12/25 Don

Chief Executive Officer

1,600 0.0064%
10/11/25 Free

Director

4,345 0.0173%
10/11/25 Other

Director

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-2.26%+1.50%+24.11%-31.11% 655M
-0.50%-1.17%-16.85%+19.88% 126B
-0.79%-3.38%-22.25%+1.32% 12.42B
+0.41%+0.02%+97.19%+152.93% 10.95B
-1.04%-8.13%-52.54%-69.79% 4.1B
+2.94%+3.55%-22.09%+54.01% 2.77B
-1.43%+7.43%-35.96%-71.44% 1.78B
-2.25%-2.62%-25.37%-14.55% 1.62B
-3.08%-5.02%-37.51%-38.93% 1.56B
Average -0.89%-0.17%-10.14%+0.26% 17.95B
Weighted average by Cap. -0.48%-1.02%-10.86%+23.66%

Financials

2026 *2027 *
Net sales 267M 229M 214M 196M 369M 25.56B 373M 2.53B 985M 12.84B 1B 981M 42.47B 299M 256M 240M 219M 413M 28.61B 418M 2.83B 1.1B 14.37B 1.12B 1.1B 47.54B
Net income -28.77M -24.66M -23.07M -21.09M -39.8M -2.76B -40.22M -273M -106M -1.38B -108M -106M -4.58B -18.48M -15.84M -14.82M -13.55M -25.56M -1.77B -25.83M -175M -68.17M -889M -69.39M -67.89M -2.94B
Net Debt - -
Logo OrthoPediatrics Corp.
OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 80 surgical and specialized bracing systems.
Employees
602
Date Price Change Volume
24/08/26 US$25.07 -2.26% 324,512
21/08/26 US$25.65 -2.21% 364,624
20/08/26 US$26.23 -1.02% 259,617
19/08/26 US$26.50 +3.92% 378,005
18/08/26 US$25.50 +3.24% 206,276
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
25.07USD
Average target price
27.22USD
Spread / Average Target
+8.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KIDS Stock